References

Unresolved reference

2019 · External reference

Cardiovascular magnetic resonance angiography: carotids, aorta, and peripheral vessels

2019 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo

10.1038/nm0195-69 · 1995 · External reference

Lesion versus lumen

10.1038/nm0195-17 · 1995 · External reference

Recent advances in 3D time-resolved contrast-enhanced MR angiography

10.1002/jmri.24880 · 2015 · External reference

Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA workshop on gadolinium chelates

10.1148/radiol.2018181151 · 2018 · External reference

Chemistry of MRI contrast agents: current challenges and new frontiers

10.1021/acs.chemrev.8b00363 · 2019 · External reference

Gadolinium-enhanced MR aortography

10.1148/radiology.191.1.8134563 · 1994 · External reference

Magnetic resonance angiography

10.1002/0471142719.mib0700s13 · 2002 · External reference

T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T

10.1097/rli.0000000000000132 · 2015 · External reference

Comparison of the relaxivities of macrocyclic gadolinium-based contrast agents in human plasma at 1.5, 3, and 7 T, and blood at 3 T

10.1097/rli.0000000000000577 · 2019 · External reference

Contrast material travel times in patients undergoing peripheral MR angiography

10.1148/radiol.2241011338 · 2002 · External reference

Bolus arterial-venous transit in the lower extremity and venous contamination in bolus chase three-dimensional magnetic resonance angiography

10.1097/00004424-200208000-00007 · 2002 · External reference

Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of radiology and the national kidney foundation

10.1148/radiol.2020202903 · 2021 · External reference

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration

10.1007/s00204-021-03189-8 · 2022 · External reference

Update on gadolinium based contrast agent safety, from the AJR special series on contrast media

10.2214/ajr.23.30036 · 2024 · External reference

Gadofosveset-enhanced magnetic resonance angiography

10.2147/vhrm.2008.04.01.1 · 2008 · External reference

Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis

10.1148/radiol.2017162740 · 2018 · External reference

Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients

10.1148/radiol.2019190485 · 2019 · External reference

Allergic-like hypersensitivity reactions to gadolinium-based contrast agents: an 8-year cohort study of 154 539 patients

10.1148/radiol.210545 · 2022 · External reference

Acute reactions to gadolinium-based contrast agents in a pediatric cohort: a retrospective study of 16,237 injections

10.2214/ajr.20.23602 · 2021 · External reference

A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis

10.1148/radiol.2019182916 · 2019 · External reference

FDA drug safety communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings

2018 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2018 · External reference

Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis

10.1001/jamainternmed.2019.5284 · 2020 · External reference

FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings

2017 · External reference

Unresolved reference

2026 · External reference

Symptoms associated with gadolinium exposure (SAGE): a suggested term

10.1148/radiol.2021211349 · 2022 · External reference

Unresolved reference

External reference

Repurposing ferumoxytol: diagnostic and therapeutic applications of an FDA-approved nanoparticle

10.7150/thno.67375 · 2022 · External reference

Emerging applications for ferumoxytol as a contrast agent in MRI

10.1002/jmri.24691 · 2015 · External reference

Ferumoxytol-enhanced MRI in children and young adults: state of the art

10.2214/ajr.22.28453 · 2023 · External reference

Comparison of gadolinium-enhanced and ferumoxytol-enhanced conventional and UTE-MRA for the depiction of the pulmonary vasculature

10.1002/mrm.27853 · 2019 · External reference

Relaxivity of ferumoxytol at 1.5 T and 3.0 T

10.1097/rli.0000000000000434 · 2018 · External reference

Brain iron deposition after ferumoxytol-enhanced MRI: a study of Porcine brains

10.7150/ntno.46356 · 2020 · External reference

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy

10.1177/20406207211018042 · 2021 · External reference

Pulmonary MRA during pregnancy: early experience with ferumoxytol

10.1002/jmri.28504 · 2023 · External reference

Ferumoxytol-enhanced pulmonary MRA in pregnancy: evaluation of initial safety and image quality

2021 · External reference

Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients

10.1007/s00330-017-4934-5 · 2018 · External reference

Vascular imaging with ferumoxytol as a contrast agent

10.2214/ajr.15.14534 · 2015 · External reference

Ferumoxytol-enhanced MRI in the peripheral vasculature

10.1016/j.crad.2018.02.021 · 2019 · External reference

Current and potential imaging applications of ferumoxytol for magnetic resonance imaging

10.1016/j.kint.2016.12.037 · 2017 · External reference

Ferumoxytol-enhanced ultrashort TE MRA and quantitative morphometry of the human kidney vasculature

10.1007/s00261-021-02984-2 · 2021 · External reference

Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI

10.1148/radiol.2019190477 · 2019 · External reference

Quantitative ferumoxytol-enhanced MRI in pregnancy: a feasibility study in the nonhuman primate

10.1016/j.mri.2019.10.006 · 2020 · External reference

UK guidelines on the management of iron deficiency in pregnancy

10.1111/bjh.16221 · 2020 · External reference

Blood pool contrast agents for venous magnetic resonance imaging

10.21037/cdt.2016.12.05 · 2016 · External reference

Optimizing three-dimensional gadolinium-enhanced magnetic resonance angiography. Original investigation

10.1097/00004424-199809000-00008 · 1998 · External reference

Delineation of simulated vascular stenosis with Gd-DTPA-enhanced 3D gradient echo MR angiography: an experimental study

10.1097/00004728-200001000-00016 · 2000 · External reference

Subtractionless compressed-sensing-accelerated whole-body MR angiography using two-point Dixon fat suppression with single-pass half-reduced contrast dose: feasibility study and initial experience

10.1186/s12968-023-00953-w · 2023 · External reference

Technical aspects of contrast-enhanced MR angiography: current status and new applications

10.2463/mrms.rev.2017-0053 · 2018 · External reference

Parallel MR imaging

10.1002/jmri.23639 · 2012 · External reference

Quantitative assessment of velocity and flow using compressed SENSE in children and young adults with adequate acquired temporal resolution

10.1186/s12968-021-00811-7 · 2021 · External reference

Breath-hold and free-breathing quantitative assessment of biventricular volume and function using compressed SENSE: a clinical validation in children and young adults

10.1186/s12968-020-00642-y · 2020 · External reference

Combining compressed sensing and parallel imaging

2008 · External reference

3D whole-heart noncontrast coronary MR angiography based on compressed SENSE technology: a comparative study of conventional SENSE sequence and coronary computed tomography angiography

10.1186/s13244-023-01378-w · 2023 · External reference

Accelerated 3D whole-heart non-contrast-enhanced mDIXON coronary MR angiography using deep learning-constrained compressed sensing reconstruction

10.1186/s13244-024-01797-3 · 2024 · External reference

Incidence of nephrogenic systemic fibrosis using Gadobenate Dimeglumine in 1423 patients with renal insufficiency compared with Gadodiamide

10.1097/rli.0000000000000259 · 2016 · External reference

Gadobenate Dimeglumine administration and nephrogenic systemic fibrosis: is there a real risk in patients with impaired renal function?

10.1148/radiol.2015142423 · 2015 · External reference

Unresolved reference

2016 · External reference

High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration

10.1148/radiol.14140364 · 2015 · External reference

High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material

10.1148/radiol.13131669 · 2014 · External reference

Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function

10.1097/rli.0000000000000252 · 2016 · External reference

Gadolinium tissue deposition in brain and bone

10.1016/j.mri.2016.08.025 · 2016 · External reference

Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats

2015 · External reference

“Black blood” T2-weighted inversion-recovery MR imaging of the heart

10.1148/radiology.199.1.8633172 · 1996 · External reference

Non-contrast enhanced MR angiography: established techniques

10.1002/jmri.22789 · 2012 · External reference

Nonenhanced MR angiography

10.1148/radiol.2481071497 · 2008 · External reference

Imaging of thoracic aortic disease

10.1259/bjr/30655825 · 2011 · External reference

Blood flow effects in magnetic resonance imaging

10.2214/ajr.143.6.1157 · 1984 · External reference

Blood flow: magnetic resonance imaging

10.1148/radiology.154.2.3966131 · 1985 · External reference

Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation

10.1148/radiographics.22.3.g02ma11651 · 2002 · External reference

Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography

10.1148/radiology.217.1.r00oc11105 · 2000 · External reference

MR angiography: basic principles and theory

10.1016/s1064-9689(21)00460-8 · 1998 · External reference

Coronary MR angiography at 3T: fat suppression versus water-fat separation

10.1007/s10334-016-0550-7 · 2016 · External reference

Cardiovascular function and flow by 4-dimensional magnetic resonance imaging techniques: new applications

10.1097/rti.0000000000000068 · 2014 · External reference

4D Flow cardiovascular magnetic resonance consensus statement: 2023 update

10.1186/s12968-023-00942-z · 2023 · External reference

4D flow cardiovascular magnetic resonance consensus statement

10.1186/s12968-015-0174-5 · 2015 · External reference

Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease

10.1186/s12968-022-00886-w · 2022 · External reference

The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

10.1056/nejm200006083422302 · 2000 · External reference

Carotid artery stenosis as a cause of stroke

10.1159/000341410 · 2013 · External reference

2024 heart disease and stroke statistics: a report of US and global data from the American heart association

10.1161/cir.0000000000001209 · 2024 · External reference

Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults

10.1161/hypertensionaha.119.13080 · 2019 · External reference

Stroke in male-to-female transgenders: a systematic review and meta-analysis

10.1017/cjn.2021.54 · 2022 · External reference

Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromso Study

10.1161/strokeaha.110.589754 · 2011 · External reference

One-year risk of stroke after transient ischemic attack or minor stroke

10.1056/nejmoa1412981 · 2016 · External reference

Cerebral angiographic risk in mild cerebrovascular disease

10.1161/01.str.21.2.209 · 1990 · External reference

ACR appropriateness criteria(R) cerebrovascular diseases-stroke and stroke-related conditions

10.1016/j.jacr.2024.02.015 · 2024 · External reference

Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis

10.1016/s0140-6736(06)68650-9 · 2006 · External reference

National variation in preoperative imaging, carotid duplex ultrasound criteria, and threshold for surgery for asymptomatic carotid artery stenosis

10.1016/j.jvs.2015.04.438 · 2015 · External reference

Dose reduction in contrast-enhanced cervical MR angiography: field strength dependency of vascular signal intensity, contrast administration, and arteriographic quality

10.2214/ajr.14.13435 · 2015 · External reference

Supraaortic arteries: contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography-feasibility study

10.1148/radiol.2493080209 · 2008 · External reference

Contrast material-enhanced MRA overestimates severity of carotid stenosis, compared with 3D time-of-flight MRA

10.1016/s0741-5214(03)00332-x · 2003 · External reference

Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography?

10.1161/01.str.26.10.1753 · 1995 · External reference

Contrast-enhanced carotid MR angiography with commercially available triggering mechanisms and elliptic centric phase encoding

10.2214/ajr.176.1.1760221 · 2001 · External reference

Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease

10.1212/01.wnl.0000167606.81882.68 · 2005 · External reference

Assessment of carotid artery atherosclerotic disease by using three-dimensional fast black-blood MR imaging: comparison with DSA

10.1148/radiol.14132687 · 2015 · External reference

Assessment of carotid stenosis using three-dimensional T2-weighted dark blood imaging: initial experience

10.1002/jmri.22839 · 2012 · External reference

Role of transthoracic lung ultrasonography in the diagnosis of pulmonary embolism: a systematic review and meta-analysis

10.1371/journal.pone.0129909 · 2015 · External reference

Fibromuscular dysplasia: what the radiologist should know: a pictorial review

10.1007/s13244-015-0382-4 · 2015 · External reference

Fibromuscular dysplasia of arteries of the head and neck: imaging findings

10.2214/ajr.162.5.8166011 · 1994 · External reference

Multifocal fibromuscular dysplasia involving the coronary arteries

10.1148/radiol.241283 · 2024 · External reference

ACR appropriateness criteria((R)) nonatherosclerotic peripheral arterial disease

10.1016/j.jacr.2019.02.026 · 2019 · External reference

Cervical-artery dissections: predisposing factors, diagnosis, and outcome

10.1016/s1474-4422(09)70084-5 · 2009 · External reference

Imaging of cervical artery dissection

10.1016/j.diii.2014.10.003 · 2014 · External reference

ACR Appropriateness Criteria® Pulsatile abdominal mass, suspected abdominal aortic aneurysm

10.1016/j.jacr.2023.08.010 · 2023 · External reference

10.1016/j.jacc.2010.11.002

10.1016/j.jacc.2010.11.002 · 2011 · External reference

Echocardiography in aortic diseases: EAE recommendations for clinical practice

10.1093/ejechocard/jeq056 · 2010 · External reference

Recommendations for transoesophageal echocardiography: update 2010

10.1093/ejechocard/jeq057 · 2010 · External reference

Guidelines from the Working Group. Recommendations for performing transesophageal echocardiography

10.1053/euje.2000.0066 · 2001 · External reference

Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging

10.1148/radiology.199.2.8668776 · 1996 · External reference

Acute traumatic thoracic aortic injuries: experience with 64-MDCT

10.2214/ajr.07.3349 · 2008 · External reference

CT and MRI assessment of the aortic root and ascending aorta

10.2214/ajr.12.9531 · 2013 · External reference

Current concepts in acute aortic syndrome

10.1016/j.yacr.2021.04.012 · 2021 · External reference

10.1093/eurheartj/ehu281

10.1093/eurheartj/ehu281 · 2014 · External reference

Assessment of reproducibility and stability of different breath-hold maneuvres by dynamic MRI: comparison between healthy adults and patients with pulmonary hypertension

10.1007/s00330-005-2795-9 · 2006 · External reference

Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols

10.1186/1532-429x-10-35 · 2008 · External reference

Highly accelerated single breath-hold noncontrast thoracic MRA: evaluation in a clinical population

10.1097/rli.0b013e31827994c2 · 2013 · External reference

Image quality and diagnostic accuracy of unenhanced SSFP MR angiography compared with conventional contrast-enhanced MR angiography for the assessment of thoracic aortic diseases

10.1007/s00330-009-1672-3 · 2010 · External reference

Non-gadolinium-enhanced 3-dimensional magnetic resonance angiography for the evaluation of thoracic aortic disease: a preliminary experience. Tex Heart Inst

2010 · External reference

Unresolved reference

External reference

What is new in dilatation of the ascending aorta? Review of current literature and practical advice for the cardiologist

10.1161/circulationaha.110.949131 · 2011 · External reference

Aortic valve and ascending aorta guidelines for management and quality measures

10.1016/j.athoracsur.2013.01.083 · 2013 · External reference

Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms

10.1016/j.athoracsur.2011.03.130 · 2011 · External reference

Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study

10.1161/jaha.114.001513 · 2015 · External reference

Unresolved reference

1997 · External reference

Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study : The Tromso Study

10.1093/aje/154.3.236 · 2001 · External reference

Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso Study, 1994-2001

10.1161/circulationaha.108.817619 · 2009 · External reference

Clinical features and management of splenic artery pseudoaneurysm: case series and cumulative review of literature

10.1016/s0741-5214(03)00710-9 · 2003 · External reference

Diagnosis and management of mycotic aneurysms

10.1016/j.clinimag.2015.11.011 · 2016 · External reference

The diagnosis of thoracic aortic dissection by noninvasive imaging procedures

10.1056/nejm199301073280101 · 1993 · External reference

Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients

10.1093/eurheartj/ehi024 · 2005 · External reference

Society for vascular surgery (SVS) and society of thoracic surgeons (STS) reporting standards for type B aortic dissections

10.1016/j.jvs.2019.11.013 · 2020 · External reference

Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis

10.1001/archinte.166.13.1350 · 2006 · External reference

Renal artery stenosis: epidemiology and treatment

2014 · External reference

Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography

10.1177/0284185113482690 · 2013 · External reference

Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization

10.1681/asn.v2111608 · 1992 · External reference

Atherosclerotic renovascular disease and progressive renal failure

10.7326/0003-4819-118-9-199305010-00010 · 1993 · External reference

Resistant hypertension and atherosclerotic renal artery stenosis: effects of angioplasty on ambulatory blood pressure. a retrospective uncontrolled single-center study

10.1161/hypertensionaha.119.13393 · 2019 · External reference

Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American heart association Task Force on practice guidelines

10.1161/cir.0b013e31828b82aa · 2013 · External reference

Assessment of the kidneys: magnetic resonance angiography, perfusion and diffusion

10.1186/1532-429x-13-70 · 2011 · External reference

Renal artery stenosis: imaging options, pitfalls, and concerns

10.1016/j.pcad.2009.10.003 · 2009 · External reference

Accuracy of unenhanced magnetic resonance angiography for the assessment of renal artery stenosis

10.1016/j.ejro.2016.07.003 · 2016 · External reference

Non-contrast MR angiography versus contrast enhanced MR angiography for detection of renal artery stenosis: a comparative analysis in 400 renal arteries

10.1007/s00261-020-02836-5 · 2021 · External reference

Mesenteric artery disease in the elderly

10.1016/j.jvs.2004.03.022 · 2004 · External reference

Significant disease of the celiac and superior mesenteric arteries in asymptomatic patients: predictive value of Doppler sonography

10.2214/ajr.161.5.8273642 · 1993 · External reference

Chronic mesenteric ischemia and therapeutic paradigm of mesenteric revascularization

10.1007/s12664-013-0377-3 · 2014 · External reference

Percutaneous transluminal angioplasty of visceral arterial stenoses: results and long-term clinical follow-up

10.1016/s1051-0443(95)71087-9 · 1995 · External reference

AGA technical review on intestinal ischemia. American Gastrointestinal Association

10.1016/s0016-5085(00)70183-1 · 2000 · External reference

Chronic mesenteric ischemia resulting from isolated lesions of the superior mesenteric artery--a case report

10.1177/000331970505600618 · 2005 · External reference

Intestinal ischemia in the elderly

10.1016/j.gtc.2009.06.002 · 2009 · External reference

Complication rates of diagnostic angiography performed by vascular surgeons

10.1177/153857440203600604 · 2002 · External reference

10.1016/0741-5214(93)90011-a

10.1016/0741-5214(93)90011-a · External reference

ACR Appropriateness Criteria (R) imaging of mesenteric ischemia

10.1007/s00261-012-9975-2 · 2013 · External reference

ACR Appropriateness Criteria((R)) Imaging of Mesenteric Ischemia

2018 · External reference

Screening for mesenteric vascular insufficiency and follow-up of mesenteric artery bypass procedures

10.1053/svas.2001.25498 · 2001 · External reference

10.1016/j.jvs.2014.01.063

10.1016/j.jvs.2014.01.063 · External reference

Comparison of noninvasive imaging modalities for stenosis grading in mesenteric arteries

10.1055/s-0033-1335212 · 2013 · External reference

Gadolinium-enhanced MR angiography of visceral arteries in patients with suspected chronic mesenteric ischemia

10.1002/jmri.1880070126 · 1997 · External reference

Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries

10.2214/ajr.166.4.8610584 · 1996 · External reference

Anatomic and radiologic review of chronic mesenteric ischemia and its treatment

10.1016/j.clinimag.2016.04.003 · 2016 · External reference

MR angiography: noninvasive vascular imaging of the abdomen

10.1007/s00261-001-0063-2 · 2002 · External reference

Computed tomography angiography and magnetic resonance angiography imaging of the mesenteric vasculature

10.1053/j.tvir.2014.12.002 · 2015 · External reference

The value of true-FISP sequence added to conventional gadolinium-enhanced MRA of abdominal aorta and its major branches

10.1016/j.ejrad.2008.09.004 · 2009 · External reference

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis

10.1016/s0140-6736(13)61249-0 · 2013 · External reference

Ethnic-specific prevalence of peripheral arterial disease in the United States

10.1016/j.amepre.2006.12.010 · 2007 · External reference

Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010

10.1016/j.gheart.2013.12.008 · 2014 · External reference

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

10.1016/j.jvs.2006.12.037 · 2007 · External reference

Peripheral arterial disease, prevalence and cumulative risk factor profile analysis

10.1177/2047487312452968 · 2014 · External reference

Novel markers of peripheral arterial disease

10.1177/1358863x09106869 · 2009 · External reference

Peripheral arterial disease detection, awareness, and treatment in primary care

10.1001/jama.286.11.1317 · 2001 · External reference

Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality

10.1016/j.jacc.2008.07.060 · 2008 · External reference

Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease

10.1016/j.atherosclerosis.2012.05.019 · 2012 · External reference

The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease

10.1016/j.ejvs.2015.10.022 · 2016 · External reference

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

10.1016/j.jacc.2013.11.005 · 2014 · External reference

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

10.1016/j.jacc.2010.09.001 · 2010 · External reference

Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study

10.1007/s10554-016-0908-y · 2016 · External reference

The natural history of claudication: risk to life and limb

1999 · External reference

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)

2000 · External reference

10.1161/circulationaha.106.174526

10.1161/circulationaha.106.174526 · 2006 · External reference

10.1016/j.jacc.2011.08.023

10.1016/j.jacc.2011.08.023 · 2011 · External reference

Use of noninvasive vascular laboratory in diagnosis of venous and arterial disease

1991 · External reference

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis

10.1001/jama.300.2.197 · 2008 · External reference

Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc

1999 · External reference

The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease

10.1007/bf02599061 · 1994 · External reference

The ratio of ankle and arm arterial pressure as an independent predictor of mortality

10.1016/0021-9150(91)90014-t · 1991 · External reference

Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review

10.1161/01.atv.0000168911.78624.b7 · 2005 · External reference

Ankle brachial index <0.9 underestimates the prevalence of peripheral artery occlusive disease assessed with whole-body magnetic resonance angiography in the elderly

10.1080/02841850701732957 · 2008 · External reference

Do the cardiovascular risk profile and the degree of arterial wall calcification influence the performance of MDCT angiography of lower extremity arteries?

10.1007/s00330-009-1555-7 · 2010 · External reference

The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality

10.1002/jmri.1880060413 · 1996 · External reference

Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS) and TSE-based subtraction techniques

10.1007/s00330-016-4448-6 · 2017 · External reference

Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography

10.1148/radiology.206.3.9494485 · 1998 · External reference

Peripheral arterial occlusive disease: 3.0-T versus 1.5-T MR angiography compared with digital subtraction angiography

10.1148/radiol.12112184 · 2013 · External reference

10.1148/radiographics.20.1.g00ja10135

10.1148/radiographics.20.1.g00ja10135 · External reference

Peripheral bolus-chase MR angiography: analysis of risk factors for nondiagnostic image quality of the calf vessels--a combined retrospective and prospective study

10.2214/ajr.08.1814 · 2009 · External reference

Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiography

10.1148/radiol.2311020845 · 2004 · External reference

Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression

10.1007/s00330-013-2833-y · 2013 · External reference

Three-station three-dimensional bolus-chase MR angiography with real-time fluoroscopic tracking

10.1148/radiol.14131603 · 2014 · External reference

White paper: interventional MRI: current status and potential for development considering economic perspectives, Part 1: general application

10.1055/s-0043-110011 · 2017 · External reference

Magnetic resonance-guided procedures: consensus on rationale, techniques, and outcomes

10.1016/j.tvir.2023.100914 · 2023 · External reference

Novel imaging techniques for the diagnosis and treatment of congenital heart defects: MR-guided interventions and beyond

10.2217/fca.11.85 · 2012 · External reference

MRI-guided cardiac catheterization in congenital heart disease: how to get started

10.1007/s11886-022-01659-8 · 2022 · External reference